Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2012
03/01/2012US20120052533 4s-iota-carrageenan sulfatase and use thereof to obtain alpha-carrageenan
03/01/2012US20120052530 Combinatorial DNA Library for Producing Modified N-Glycans in Lower Eukaryotes
03/01/2012US20120052529 Episomal expression vector for metazoan cells
03/01/2012US20120052510 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
03/01/2012US20120052487 Methods and compositions for selecting sirna of improved functionality
03/01/2012US20120052479 Methods, compositions and devices for inducing stasis in tissues and organs
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052089 Newcastle disease virus vectored herpesvirus vaccines
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052073 Antibodies Directed to Angiopoietin-2 And Uses Thereof
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052043 Chemokine-Chaperone Fusion Proteins
03/01/2012DE102010039833A1 Ganzzell-Biotransformation von Fettsäuren zu den um ein Kohlenstoffatom verkürzten Fettaldehyden Whole-cell biotransformation of fatty acids to the shortened by one carbon atom fatty aldehydes
03/01/2012DE102010036111A1 Pretreatment method for isolating and concentrating nucleic acids from environmental sample, comprises adding pretreatment solution to environmental sample, thermolyzing, sedimenting, clarifying by centrifugation, and further processing
03/01/2012DE102010035702A1 Ganzzell-Biokatalysator Whole-cell biocatalyst
03/01/2012CA2812390A1 Whole-cell biocatalyst
03/01/2012CA2809433A1 Dual variable domain immunoglobulins and uses thereof
03/01/2012CA2809363A1 Hiv core protein specific antibodies and uses thereof
03/01/2012CA2809342A1 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
03/01/2012CA2809214A1 Plants having enhanced yield-related traits and method for making the same
03/01/2012CA2809089A1 Anti-ox40 antibodies and methods of using the same
03/01/2012CA2808889A1 Mir-33 inhibitors and uses thereof
03/01/2012CA2808777A1 Filamentous fungi having an altered viscosity phenotype
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
03/01/2012CA2808418A1 Antibodies to matrix metalloproteinase 9
03/01/2012CA2808002A1 Mutant hpgg motif and hdash motif delta-5 desaturases and their use in making polyunsaturated fatty acids
03/01/2012CA2808000A1 Mutant delta-9 elongases and their use in making polyunsaturated fatty acids
03/01/2012CA2807834A1 Recombinant microbial host cells for high eicosapentaenoic acid production
03/01/2012CA2807785A1 Novel defensin variants and methods of use
03/01/2012CA2807505A1 Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
03/01/2012CA2802721A1 Novel agonists of toll-like receptor 3 and methods of their use
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423324A1 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
02/29/2012EP2423323A1 Method for evaluating cancer
02/29/2012EP2423322A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits
02/29/2012EP2423320A1 Process for production of (r)-3-quinuclidinol
02/29/2012EP2423317A2 Plants with modulated expression of RAN binding protein (RANB) having enhanced yield-related traits and a method for making the same
02/29/2012EP2423316A1 Method for determining meiotic recombination frequencies in plants
02/29/2012EP2423315A1 A method for achieving improved polypeptide expression
02/29/2012EP2423314A1 Vector systems
02/29/2012EP2423313A1 Method for production of chrysanthemum plant having petals containing modified anthocyanin
02/29/2012EP2423312A1 Method for production of chrysanthemum plant having delphinidin-containing petals
02/29/2012EP2423311A1 Method for preparing cell pharmaceutical
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2423309A1 Method for preparing cell highly producing heterogeneous protein
02/29/2012EP2423307A1 Modified coagulation factor IV polypeptides and use thereof for treatment
02/29/2012EP2423306A1 Modified coagulation factor IX polypeptides and use thereof for treatment
02/29/2012EP2423305A1 Modified coagulation factor IX polypeptides and use thereof for treatment
02/29/2012EP2423304A1 Use of a RNA ligase
02/29/2012EP2423231A2 PRLR-specific antibody and uses thereof
02/29/2012EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein
02/29/2012EP2423224A1 Compositions and methods for modulating hemostasis
02/29/2012EP2423218A1 Tag peptide having protease recognition sequence and utilization of same
02/29/2012EP2423217A1 Peptide and protein affinity tag from mistic protein
02/29/2012EP2423216A1 Replication competent hepatitis C virus and methods of use
02/29/2012EP2423176A1 Carboxylic acid compound
02/29/2012EP2422819A2 Compositions and their uses directed to Huntingtin
02/29/2012EP2422615A2 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
02/29/2012EP2421994A2 Bin1 as a prognostic marker in cardiovascular disease
02/29/2012EP2421986A1 Process for the production of a recombinant polypeptide of interest
02/29/2012EP2421985A1 Yield enhancement in plants by modulation of a maize transcription coactivator p15 (pc4) protein
02/29/2012EP2421982A1 Method for the production of recombinant polyomaviral vector particles
02/29/2012EP2421981A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
02/29/2012EP2421980A2 Genetically modified rat models for cancer
02/29/2012EP2421979A1 Drought responsive expression of genes from the zea mays rab17 promoter
02/29/2012EP2421978A1 Rna-mediated induction of gene expression in plants
02/29/2012EP2421977A1 Multiple virus resistance in plants
02/29/2012EP2421976A1 Whole seed specific promoter
02/29/2012EP2421975A1 Production of multi-antennary n-glycan structures in plants
02/29/2012EP2421974A1 Rna-mediated induction of gene expression in plants
02/29/2012EP2421973A1 Proteases with modified pro regions
02/29/2012EP2421972A2 Modulation of gene expression using oligomers that target gene regions downstream of 3' untranslated regions
02/29/2012EP2421971A1 Oligonucleotide comprising an inosine for treating dmd
02/29/2012EP2421970A1 Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
02/29/2012EP2421969A2 Selective detection of bordetella species
02/29/2012EP2421968A1 Method for the treatment of acute myeloid leukemia
02/29/2012EP2421967A2 Compositions, kits and methods for promoting ischemic and diabetic wound healing
02/29/2012EP2421965A1 Carbohydrate degrading polypeptide and uses thereof
02/29/2012EP2421963A2 Method
02/29/2012EP2421958A1 Methods for mitochondrial dna replacement in oocytes
02/29/2012EP2421955A1 Methods for obtaining fetal genetic material
02/29/2012EP2421890A1 Method of producing polymers of spider silk proteins
02/29/2012EP2421880A1 Nucleic acid delivery compositions and methods
02/29/2012EP2421542A1 Foamyvirus vectors and methods of use
02/29/2012EP2421357A1 Animal models and therapeutic molecules
02/29/2012EP2395085A9 Small interference rna complex with increased intracellular transmission capacity
02/29/2012EP2368989A9 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
02/29/2012EP2195021B1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
02/29/2012EP2099913B1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
02/29/2012EP2069495B1 Nucleic acid purification method
02/29/2012EP1916306B1 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against leishmaniasis
02/29/2012EP1844152B1 Production of antibodies in plants with plus-sense single-stranded viral rna vectors
02/29/2012EP1799815B1 Novel laccase enzymes and their uses
02/29/2012EP1767639B1 Oral anti-leucocytozoonosis vaccines based on transgenic plants
02/29/2012EP1670826B1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
02/29/2012EP1546405B1 Method for screening of a lipase having improved enzymatic activity using yeast surface display vector and the lipase
02/29/2012EP1546399B1 Terminal phosphate blocked nucleoside polyphosphates
1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 4023